Chapter
CHAPTER 3. IN VITRO COMPARISON OF TF OBTAINED FROM SKIN TEST POSITIVE AND NEGATIVE INDIVIDUALS
CHAPTER 4. TRANSFER FACTOR: IN VITRO EFFECTS ON LYMPHOCYTE TRANSFORMATION
CHAPTER 5. AUGMENTATION OF LYMPHOCYTE TRANSFORMATION BY DIALYSABLE TRANSFER FACTOR
Discussion and conclusions
CHAPTER 6. LEUCOCYTE DIALYSATES REQUIRE PRECOMMITTED, ANTIGEN-REACTIVE CELLS TO AUGMENT LYMPHOCYTE PROLIFERATION
CHAPTER 7. EXPERIMENTAL STUDIES OF TRANSFER FACTOR
1. IN VITRO STUDIES OF TF IN MAN
2. IN VITRO STUDIES OF LEUKOCYTE EXTRACTS IN THE MOUSE
CHAPTER 8. SPECIFIC AND NONSPECIFIC EFFECTS OF TRANSFER FACTOR - DIALYZABLE LEUKOCYTE EXTRACTS
CHAPTER 9. IN VITRO CHARACTERIZATION OF THE TARGET CELL FOR TRANSFER FACTOR - DIALYZABLE LEUKOCYTE EXTRACTS
SECTION II: IN VITRO STUDIES OF TRANSFER FACTOR – Il
CHAPTER 10. ACQUISITION OF MIXED CELL MIGRATION REACTIVITY BY ACTIVELY SENSITISED AND TRANSFER-FACTOR TREATED RHESUS MONKEYS
Discussion and conclusions
CHAPTER 11. IN VITRO ASSAY FOR TRANSFER FACTOR USING DIRECT MIGRATION INHIBITION
CHAPTER 12. IN VITRO ASSAY FOR TRANSFER FACTOR BY MEANS OF LEUKOCYTE MIGRATION TEST (LMT)
CHAPTER 13. POTENTIATING EFFECT OF TRANSFER FACTOR UPON MACROPHAGE MIGRATION INHIBITION IN VITRO
Discussion and conclusions
CHAPTER 14. EFFECTS OF DIALYZABLE TRANSFER FRACTOR ON ACCUMULATION OF CYCLIC NUCLEOTIDES BY LEUKOCYTES
CHAPTER 15. STUDIES WITH IN VITRO PRODUCED TRANSFER FACTOR
CHAPTER 16. Guinea Pig "Transfer Factor" In Vitro: Physico-chemical Properties and Partial Purification
CHAPTER 17. In Vitro Transfer of Coccidioidin and Histoplasmin Sensitivity to "Nonsensitive" Leucocytes Utilizing Whole Cell Lysates from Skin Test Positive Coccidioidin Sensitive Humans: Evidence of Cross Reactivity in a Transfer System
Materials and Methods-Skin Testing of Human Donors
CHAPTER 18. PRODUCTION OF SHEEP ERYTHROCYTE ROSETTE FORMING CELLS BY LYMPHOCYTES CULTURED WITH LEUCOCYTE DIALYSATES
SECTION III:
CHARACTERIZATION OF TRANSFER FACTOR
CHAPTER 19. IDENTIFICATION OF HYPOXANTHINE AS THE MAJOR COMPONENT OF CHROMATOGRAPHICALLY PREPARED TRANSFER FACTOR
CHAPTER 20. TRANSFER FACTOR - SOME BIOCHEMICAL OBSERVATIONS
CHAPTER 21. LOCAL TRANSFER OF DELAYED HYPERSENSITIVITY TO DOGS BY HUMAN TRANSFER FACTOR
CHAPTER 22. QUANTITATION OF TRANSFER FACTOR
CHAPTER 23. SOME PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES OF A TRANSFER FACTOR PREPARATION AND ITS CLINICAL APPLICATION
Characteristics of TFz donors
Physico-chemical properties
CHAPTER 24. ARJA UOTILA, KAI KROHN AND JUHANI VÄISÄNEN
CHAPTER 25. CHROMATOGRAPHY OF TRANSFER FACTOR AND ASSAY OF FRACTIONS IN VITRO
CHAPTER 26. Fractionation of Rhesus Monkey Dialyzable KLH- Transfer Factor and the in vitro Assay of Specific Biologic Activity Using the Indirect MIF Assay
Preparation of Supernatant Fluids from Lymphocytesb Incubated with TFd and KLH
G-25 Sephadex Chromatography and Characterization of TFd
The Effect on PEC Migration of Supernatant Fluids Derived From KLH Negative Leucocytes Incubated With TFd and KLH
CHAPTER 27. BOVINE TRANSFER FACTOR: ISOLATION AND CHARACTERISTICS
CHAPTER 28. BIOLOGICAL ACTIVITY OF SUBFRACTION OF HUMAN TRANSFER FACTOR
CHAPTER 29. FRACTIONATION OF TRANSFER FACTOR WITH HIGH PRESSURE LIQUID CHROMATOGRAPHY AND E-ROSETTE ENHANCING ACTIVITY OF VARIOUS FRACTIONS
High Pressure Liquid Chromatography
Thin Layer Chromatography
SUPPLEMENTAL GENERAL DISCUSSION
SUPPLEMENTAL GENERAL DISCUSSION
SECTION IV:
ANIMAL MODELS OF TRANSFER FACTOR
CHAPTER 30. CANINE TRANSFER FACTOR
CHAPTER 31. "NON-SPECIFIC" EFFECTS OF HUMAN DIALYZABLE TRANSFER FACTOR
CHAPTER 32. TRANSFER OF CELLULAR REACTIVITY TO 3 NONHUMAN PRIMATE SPECIES WITH HUMAN AND BABOON TRANSFER FACTOR
CHAPTER 33. PREVENTION OF HERPES SIMPLEX VIRUS TYPE 1 FATAL DISSEMINATION IN PRIMATES WITH HUMAN TRANSFER FACTOR
CHAPTER 34. TRANSFER OF DELAYED HYPERSENSITIVITY TO MICE WITH HUMAN IMMUNE CELL EXTRACTS
CHAPTER 35. Human Transfer Factor in Guinea Pigs: Further Studies
CHAPTER 36. HUMAN TRANSFER FACTOR IN GUINEA PIGS: PARTIAL PURIFICATION OF THE ACTIVE COMPONENT
CHAPTER 37. HUMAN TRANSFER FACTOR: TRIALS WITH AN ASSAY IN GUINEA PIGS
Correlation of in vivo and in vitro activity of guinea pig transfer factor
SECTION V:
TRANSFER FACTOR IN INFECTIOUS DISEASES
CHAPTER 38. Transfer Factor Therapy of Chronic Aggressive Hepatitis
CHAPTER 39. Attempted Immunotherapy with Dialyzable Transfer Factor in Hepatitis B Carrier Chimpanzees: Induction of Delayed Hypersensitivity to Hepatitis B Surface Antigen (HBsAg)
CHAPTER 40. TRANSFER FACTOR TREATMENT OF VIRAL DISEASES IN MILWAUKEE
CHAPTER 41. PRELIMINARY RESULTS ON THE SAFETY AND EFFICACY OF TRANSFER FACTOR IN LEPROSY
CHAPTER 42. CLINICAL AND IMMUNOLOGIC RESULTS OF TRANSFER FACTOR THERAPY IN COCCIDIOIDOMYCOSIS
CHAPTER 43. COMBINATION TRANSFER FACTOR-AMPHOTERICIN B THERAPY IN A CASE OF CHRONIC MUCOCUTANEOUS CANDIDIASIS: A CONTROLLED STUDY
CHAPTER 44. Immunological Reconstitution of Chronic Mucocutaneous Candidiasis with Transfer Factor and Fetal Thymic Tissue
CHAPTER 45. TRANSFER FACTOR THERAPY OF DISSEMINATED HISTOPLASMOSIS
CHAPTER 46. SUPPLEMENTAL GENERAL DISCUSSION
SUPPLEMENTAL GENERAL DISCUSSION
SECTION VI:
TRANSFER FACTOR IN NEOPLASTIC DISEASES
CHAPTER 47. TRANSFER FACTOR IMMUNOTHERAPY IN CANCER
CHAPTER 48. An Unusual Metastatic Lesion in a Patient with Osteosarcoma Receving Tumor Specific Transfer Factor
CHAPTER 49. IMMUNOTHERAPY OF HUMAN NEOPLASMS WITH TRANSFER FACTOR
CHAPTER 50. ADJUNCTIVE TRANSFER FACTOR IN OSTEOGENIC SARCOMA: I. CLINICAL IMPLICATIONS OF CHEMOTHERAPY AND IMMUNOTHERAPY
MATERIALS, METHODS AND RESULTS
CHAPTER 51. Case Discussion: Undifferentiated Sarcoma
CHAPTER 52. ADJUNCTIVE TRANSFER FACTOR IN OSTEOGENIC SARCOMA: II. METHODOLOGY AND RESULTS OF THE IMMUNOLOGICAL STUDIES
CHAPTER 53. TRANSFER FACTOR THERAPY IN DISSEMINATED NEOPLASMS
CHAPTER 54. CLINICAL TRIALS WITH TRANSFER FACTOR
SECTION VII: TRANSFER FACTOR THERAPY
CHAPTER 55. THE ROLE OF TRANSFER FACTOR IN THE TREATMENT OF LYMPHOMA CUTIS IN WISKOTT-ALDRICH SYNDROME
CHAPTER 56. The Effect of a Chromatographically Purified Transfer Factor Component on Juvenile Rheumatoid Arthritis
CHAPTER 57. TRANSFER FACTOR IMMUNOTHERAPY OF RHEUMATOID ARTHRITIS
CHAPTER 58. Transfer Factor Therapy in a Patient with an Isolated T-cell Deficiency
Immunological Studies: B-cell System
CHAPTER 59. EFFECTS OF TRANSFER FACTOR IN WALDENSTROM'S MACROGLOBULINEMIA AND MULTIPLE MYELOMA
CHAPTER 60. TRANSFER FACTOR TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS
CHAPTER 61. TRANSFER OF PROTECTIVE IMMUNITY TO FRIEND LEUKEMIA VIRUS BY CELL FREE EXTRACTS OF IMMUNE LYMPHOID CELLS
General Experimental Procedures
Discussion and Conclusions
CHAPTER 62. LEUKAPHERESIS OF CANCER PATIENTS FOR ADOPTIVE IMMUNOTHERAPY
CHAPTER 63. TRANSFER FACTOR AND SKIN GRAFTS
CHAPTER 64. ON THE NATURE OF TRANSFER FACTOR
CHAPTER 65. INVESTIGATIONS ON THE TRANSFER OF CELLULAR IMMUNITY IN ANIMAL MODEL SYSTEM BY THE TRANSFER FACTOR
CHAPTER 66. HUMAN "TRANSFER FACTOR" ACTIVITY IN GUINEA PIGS
CHAPTER 67. Lymphocyte Antigen Sensitivity As A Requirement for a Blastogenic Response to Transfer Factor
CHAPTER 68. Leishmania enriettii Infections in Guinea Pigs and Transfer Factor Obtained from Convalescent yet Immune Animals
CHAPTER 69. CLINICAL EVALUATION OF THE EFFECTS OF TRANSFER FACTOR ON MULTIPLE SCLEROSIS
Patient Selection and Procedure
Preparation of Transfer Factor
Case Descriptions Are Given in Table I
SECTION VIII: KEYNOTE ADDRESS
CHAPTER 70. A BIOCHEMIST'S VIEW OF THE MEDIATORS OF CELLULAR IMMUNITY, WITH SPECIAL REFERENCE TO TRANSFER FACTOR
In Vitro Production of TF
Newer Animal Models for TF Activity
Transfer Factor
：Basic Properties and Clinical Applications
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
